atenolol has been researched along with Polycystic Kidney, Autosomal Dominant in 1 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
Polycystic Kidney, Autosomal Dominant: Kidney disorders with autosomal dominant inheritance and characterized by multiple CYSTS in both KIDNEYS with progressive deterioration of renal function.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We designed a study investigating the effect of enalapril on the protection of renal function in autosomal dominant polycystic kidney disease (ADPKD)." | 5.10 | No effect of enalapril on progression in autosomal dominant polycystic kidney disease. ( Breuning, MH; Duiser, R; van Dijk, MA; van Es, LA; Westendorp, RG, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| van Dijk, MA | 1 |
| Breuning, MH | 1 |
| Duiser, R | 1 |
| van Es, LA | 1 |
| Westendorp, RG | 1 |
1 trial available for atenolol and Polycystic Kidney, Autosomal Dominant
| Article | Year |
|---|---|
No effect of enalapril on progression in autosomal dominant polycystic kidney disease.
Topics: Adrenergic beta-Antagonists; Adult; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Double-Blind | 2003 |